0000920148-24-000020.txt : 20240329
0000920148-24-000020.hdr.sgml : 20240329
20240329170706
ACCESSION NUMBER: 0000920148-24-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240327
FILED AS OF DATE: 20240329
DATE AS OF CHANGE: 20240329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilkinson Peter J
CENTRAL INDEX KEY: 0001398138
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 24804721
MAIL ADDRESS:
STREET 1: C/O PHARMACEUTICAL PRODUCT DEVELOPMENT
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-27
0
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001398138
Wilkinson Peter J
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
0
1
0
0
SVP, Chief Accounting Officer
0
Common Stock
2024-03-27
4
M
0
3079
A
5420.2194
D
Common Stock
2024-03-27
4
F
0
894
216.57
D
4526.2194
D
Restricted Stock Unit
2024-03-27
4
M
0
3079
D
Common Stock
3079
791
D
Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.
Stock withholding to satisfy tax withholding obligations.
As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024.
This number reflects the aggregate number of RSUs held by the reporting person.
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Peter J. Wilkinson
2024-03-29